Treatment with cenobamate may reduce seizure frequency among patients with drug-resistant epilepsy after 3 months.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Explore DiaMedica's Q1 2025 earnings call. Key updates on preeclampsia and stroke trials, cash runway into Q3 2026, and upcoming trial results discussed.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...